CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Announces Private Placement, Date for Release of Q4 Earnings

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) on Tuesday announced a non-brokered private placement for gross proceeds of C$20,000,000, with, at the company’s discretion, the ability to upsize the amount to an aggregate gross proceeds of C$25,000,000. According to the update, the company expects to use the proceeds of the Offering for general working capital purposes. “Despite the challenging capital markets environment, we are extremely fortunate to announce this financing and to have continued support from management and insiders who have been instrumental in Flowr’s founding, strategic direction and financing since inception,” Flowr’s CEO Vinay Tolia stated in the news release. “This capital is expected to enable Flowr to become cash flow positive in H2 2020 as we build on our focus of delivering premium dry flower to the Canadian marketplace driven by our flagship product BC Pink Kush and other high THC strains we will be launching imminently as all of our 20 grow rooms in our Kelowna 1 facility will soon be in harvest cycles.  We expect to continue to achieve premium price points in the market with our optimized library of high THC strains.  Future revenue growth will be further enhanced with contributions from Holigen given the recent receipt of our EU GMP license in Portugal.”

In addition, Flowr announced that it will release its fourth quarter 2019 results after the close of the financial markets on Wednesday, April 29, 2020, followed by a 5:30 PM Eastern Time conference call and webcast to review these results. Interested parties may access the call by dialing 1-833-227-5845 (Toll Free) or 1-647-689-4072 (Toll/International). The webcast may be accessed by visiting www.FlowrCorp.com/Investors

To view the full press release, visit http://cnw.fm/l3KBT

About The Flowr Corporation

The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility that is currently under construction. From this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal and Australia. Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products. For more information, please visit www.Flowr.ca.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Texas Governor Signs Bill to Expand Medical Marijuana Program

On Friday last week (June 14), Gov. Greg Abbott signed a bill that is focused on increasing the number of qualifying conditions for which patients can be licensed to use medical marijuana in the state.

House Bill 3703 gives doctors permission to recommend any patient who suffers from seizure disorders (intractable epilepsy, for example), spasticity, Parkinson’s, multiple sclerosis, autism and several other conditions to access medical marijuana whose THC content doesn’t exceed 0.5 percent from the dispensaries licensed by the state.

Joshua Raine, an Army veteran suffering from post-traumatic stress disorder, is one of the patients who pleaded with legislators to include PTSD among the qualifying conditions for which someone can use medical marijuana.

He told the lawmakers that he has lost more friends (who are veterans) to suicide induced by PTSD than the number of friends he lost during combat operations. He admitted that without medical marijuana, he too could have committed suicide.

Blake Novacek is another patient who is likely to benefit from the enactment of this law. He was attacked violently during a fraternity pledge and that attack caused him to develop seizures. In fact, while waiting to talk to legislators during the debate on the medical marijuana expansion bill, Novacek started convulsing violently as the gravity of his situation showed itself at the state Capitol.

His father (a former Dallas Cowboys player) and mother pleaded to be given a chance to access medical cannabis legally so that they can save the life of their son. In the past, cannabis has helped massively, they added.

Texas is one of the most conservative states in terms of marijuana policy reform. The marijuana program in this state is so restrictive that the only form of medical cannabis allowed is cannabis oil whose THC content is much lower than what advocates say is required for therapeutic purposes.

Nonetheless, advocates are glad that the state has taken this modest step to expand the list of qualifying conditions from the very narrow version which has existed since low-THC cannabis oil was legalized as a form of treatment. Activists hope that more incremental reforms will be enacted until Texas’ medical marijuana program is at par with programs in other states.

Many Texans keep wondering how companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) handle the frustration of thinking that a major decision was made without paying ample attention to the scientific information available but instead unfounded fears took the day.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cancer Patient Launches Legal Challenge to Michigan Cannabis Testing Rules

Sherry Hoover, a retired nurse suffering from stage 4 cancer, has taken Michigan to court to challenge its newly imposed medical marijuana testing rules. The lawsuit filed in a federal court seeks to obtain a temporary restraining order so that the plaintiff can continue accessing her marijuana-derived medicine which has since become hard to obtain due to the new testing rules imposed by the state regulator.

The 57-year old plaintiff was diagnosed with mastocytosis leukemia in 2011. She used several prescription drugs, such as fentanyl patches and Norco, with limited effect until she discovered that medical marijuana could improve her appetite, alleviate her pain and enable her to sleep better.

Before April 1 this year, LARA (Licensing and Regulatory Affairs) permitted untested medical marijuana products to be sold in medical marijuana dispensaries. However, those untested tinctures, oils and other medicinal products made by registered caregivers would no longer be sold without being tested once the April 1 deadline passed.

The testing rules have since taken effect, and Hoover is finding it hard to access the products which have been instrumental in giving her a better quality of life. The lawsuit she filed on Wednesday (June 5) seeks to compel the state to extend the commencement of enforcing the testing rules to December 31.

She argues that the current restrictions have resulted in stock-outs in the only two licensed medical marijuana dispensaries which carried the products she uses. Continuing to enforce the testing rules may therefore leave her with no choice but to resort to the black market for her medicine, a step she doesn’t want to take.

The suit states that the four licensed testing facilities cannot cope with the demand for testing services from licensed cultivators, manufacturers and caregivers. Additionally, the added steps, such as transporting the untested products to the testing facilities and then hiring transport firms permitted to carry tested products to medical marijuana dispensaries prolongs the duration needed to get tinctures and other medical marijuana products made by caregivers to the dispensing points where patients can buy them.

In short, Hoover argues in her suit that the state is violating her rights of access to medical marijuana products and yet she is licensed and duly authorized to use such products.

This isn’t the first time that Sherry Hoover is suing the state. Last year, she successfully sued LARA to compel it to extend deadline imposed for unlicensed dispensaries to get the necessary permits or close by December 31, 2018. Her lawsuit was successful and the deadline was extended to April 1 this year.

Sugarmade Inc. (OTCQB: SGMD) longs for the day when all the kinks in the way medical marijuana is regulated are fixed so that these seemingly endless deadline extensions and lawsuits in Michigan come to an end.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com